Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders

Background: Animal models of depression and psychopharmacological mechanisms of action suggest the importance of the gamma-amino butyric acid (GABA) system in the pathophysiology of mood disorders. Mood stabilizers have overlapping effects on GABAergic neurotransmission, and antidepressant use has been associated with alterations in GABAB receptor function. Magnetic resonance spectroscopy (MRS) provides an opportunity to noninvasively assess cerebral GABA concentrations in anterior paralimbic circuits that have been implicated in mood disorders. Methods: In bipolar disorder patients and healthy control subjects, we used MRS with a modified GABA-edited point resolved spectroscopy sequence (TE 68 ms, TR 1500 ms, 512 averages, total scan time 26 min) to assess GABA in an 18-cm3 occipital voxel. In addition, in another cohort of bipolar disorder patients and healthy control subjects, we similarly assessed GABA in a 12.5-cm3 medial prefrontal/anterior cingulate (MPF/AC) voxel. The concentration of GABA was referenced to creatine (Cr) from unedited spectra. Results: In bipolar patients and controls, we consistently detected 3.0 p.p.m. GABA peaks in occipital lobe and MPF/AC. In 16 bipolar (nine bipolar I and seven bipolar II) disorder patients, compared with six healthy control subjects, mean occipital GABA/Cr concentration was 61% higher. In addition, in 15 bipolar (five bipolar I, nine bipolar II, and one bipolar not otherwise specified) disorder patients, compared with six healthy control subjects, mean MPF/AC GABA/Cr concentration tended to be 41% higher. Conclusions: Patients with bipolar disorders may have increased cerebral GABA concentrations. Although this was more evident in the occipital lobe, MPC/AC GABA disturbance may be of greater potential interest in view the more established role of MPF/AC in affective processing. Additional studies are warranted to assess changes in GABAergic neurotransmission and the influences of diagnosis, mood state, and medication status in bipolar disorder patients.

[1]  Gregor Hasler,et al.  Normal Prefrontal Gamma-Aminobutyric Acid Levels in Remitted Depressed Subjects Determined by Proton Magnetic Resonance Spectroscopy , 2005, Biological Psychiatry.

[2]  A. Stoll,et al.  Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder , 2004, Biological Psychiatry.

[3]  In Kyoon Lyoo,et al.  Brain metabolic alterations in medication-free patients with bipolar disorder. , 2004, Archives of general psychiatry.

[4]  J. Krystal,et al.  Increased cortical GABA concentrations in depressed patients receiving ECT. , 2003, The American journal of psychiatry.

[5]  J. Krystal,et al.  Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. , 2002, The American journal of psychiatry.

[6]  Jun Shen,et al.  In vivo GABA editing using a novel doubly selective multiple quantum filter , 2002, Magnetic resonance in medicine.

[7]  C. Tamminga,et al.  Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia‐thalamocortical neural pathways , 2001, Synapse.

[8]  J. Lieberman,et al.  Olanzapine increases allopregnanolone in the rat cerebral cortex , 2000, Biological Psychiatry.

[9]  Fahmeed Hyder,et al.  Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy , 1999 .

[10]  B. Dean,et al.  Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors. , 1998, European journal of pharmacology.

[11]  A. Guidotti,et al.  Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Guidotti,et al.  Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Mattson,et al.  The effect of gabapentin on brain gamma‐aminobutyric acid in patients with epilepsy , 1996, Annals of neurology.

[14]  R. Post,et al.  Functional Brain Imaging, Limbic Function, and Affective Disorders , 1996 .

[15]  K. Behar,et al.  Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy , 1995, Acta neurologica Scandinavica. Supplementum.

[16]  F. Petty.  GABA and mood disorders: a brief review and hypothesis. , 1995, Journal of affective disorders.

[17]  W. Löscher,et al.  Differential effects of vigabatrin, γ-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma , 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  N. Bowery,et al.  Repeated administration of desipramine and a GABAB receptor antagonist, CGP 36742, discretely up‐regulates GABAB receptor binding sites in rat frontal cortex , 1993, British journal of pharmacology.

[19]  L. Fowler,et al.  The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus: an in vivo microdialysis study , 1992, Brain Research.

[20]  Motohashi Nobutaka.  GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate , 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  B. Scatton,et al.  The gabaergic hypothesis of depression , 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  N. Motohashi,et al.  GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders? , 1989, European journal of pharmacology.

[23]  R. Macdonald,et al.  Differential regulation of γ‐aminobutyric acid receptor channels by diazepam and phenobarbital , 1989 .

[24]  N. Mataga,et al.  Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disorders. , 1988, The Journal of pharmacology and experimental therapeutics.

[25]  A. Meli,et al.  On the role of endogenous GABA in the forced swimming test in rats , 1988, Pharmacology Biochemistry and Behavior.

[26]  G. M. Goodwin,et al.  Hypothermia induced by baclofen, a possible index of GABAB receptor function in mice, is enhanced by antidepressant drugs and ECS , 1987, British journal of pharmacology.

[27]  J. Gray,et al.  Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks , 1987, British journal of pharmacology.

[28]  N. Bowery,et al.  GABAA and GABAB receptor site distribution in the rat central nervous system , 1987, Neuroscience.

[29]  T. Higuchi,et al.  Effects of carbamazepine and valproic acid on brain immunoreactive somatostatin and gamma-aminobutyric acid in amygdaloid-kindled rats. , 1986, European journal of pharmacology.

[30]  M. Rubio,et al.  Acute and chronic effects of lithium chloride on GABA-ergic function in the rat corpus striatum and frontal cerebral cortex , 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

[31]  B. Sadasivudu,et al.  Acute and short-term effects of lithium on glutamate metabolism in rat brain. , 1986, Biochemical pharmacology.

[32]  K. Lloyd,et al.  Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. , 1985, The Journal of pharmacology and experimental therapeutics.

[33]  W. Löscher,et al.  Comparison of the anticonvulsant effects of two novel GABA uptake inhibitors and diazepam in amygdaloid kindled rats , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[34]  F. Petty,et al.  GABAergic modulation of learned helplessness , 1981, Pharmacology Biochemistry and Behavior.

[35]  P. Patsalos,et al.  Changes in Regional Brain Levels of Amino Acid Putative Neurotransmitters After Prolonged Treatment with t he Anticonvulsant Drugs Diphenylhydantoin, Phenobarbitone, Sodium Valproate, Ethosuximide, and Sulthiame in the Rat , 1981, Journal of neurochemistry.

[36]  F. Petty,et al.  Neurochemical basis of the action of antidepressants on learned helplessness. , 1980, Behavioral and neural biology.

[37]  C. Marsden.  GABA in Nervous System Function , 1977 .

[38]  L. Iversen,et al.  The use of autoradiographic techniques for the identification and mapping of transmitter-specific neurones in the brain. , 1974, Life sciences.

[39]  Z. Gottesfeld,et al.  Effect of lithium on concentrations of glutamate and GABA levels in amygdala and hypothalamus of rat. , 1971, Nature: New biology.

[40]  S. Fahn,et al.  REGIONAL DISTRIBUTION OF γ‐AMINOBUTYRIC ACID (GABA) IN BRAIN OF THE RHESUS MONKEY * , 1968, Journal of neurochemistry.

[41]  G F Mason,et al.  Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. , 1999, Archives of general psychiatry.

[42]  N. Motohashi,et al.  GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. , 1992, Progress in neuro-psychopharmacology & biological psychiatry.

[43]  T. Higuchi,et al.  Effects of anticonvulsants and gamma-aminobutyric acid (GABA)-mimetic drugs on immunoreactive somatostatin and GABA contents in the rat brain. , 1990, Life sciences.

[44]  R. Macdonald,et al.  Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital. , 1989, Annals of neurology.

[45]  P. Soubrié,et al.  Decreased GABA B receptors in helpless rats: reversal by tricyclic antidepressants. , 1989, Neuropsychobiology.

[46]  M. Rubio,et al.  GABAergic responses to lithium chloride: dependence on dose, treatment length and experimental condition. , 1986, Advances in biochemical psychopharmacology.

[47]  P. Morselli,et al.  GABA and mood disorders : experimental and clinical research , 1986 .

[48]  B. Scatton,et al.  The GABA hypothesis of depression and antidepressant drug action. , 1985, Psychopharmacology bulletin.

[49]  E. Hitchcock,et al.  Anticonvulsant activation of pain-suppressive systems. , 1982, Applied neurophysiology.

[50]  R. L. Singhal,et al.  Brain gabaergic and dopaminergic systems following lithium treatment and withdrawal. , 1981, Progress in neuro-psychopharmacology.